| Halkımızda koroner hastalığın başsuçlusu metabolik sendrom: Sıklığı, unsurları, koroner risk ile ilişkisi ve yüksek risk kriterleri | Altan ONAT, Vedat SANSOY | 8–15 |
| Effects of ticlopidine to in-vitro platelet aggregation responce induced by agonists in coronary stenting patients | Abdi SAĞCAN, Azem AKILLI, Cüneyt TÜRKOĞLU, Serdar Bedii OMAY, Mustafa AKIN | 16–21 |
| Effects of glycoprotein IIb / IIIa receptor inhibution on early and long-term prognosis in high-risk patients with non-ST elevation acute coronary syndromes without early invasive intervention | Ertan ÖKMEN, Hülya KAŞIKÇIOĞLU, Hüseyin TUNAR, Arda ŞANLI, Recep ÖZTÜRK, Neşe ÇAM, İzzet ERDİNLER, Zeynep TARTAN | 22–29 |
| Detection of Arg403Gln, Arg453Cyn, Arg719Trp and Arg719Gln mutations in the beta-myosin heavy chain gene (Beta-Mhc) causing to hypertropic cardiomyopathy | F. Sırrı ÇAM, Murat ÖZDAMAR, İstemi NALBANTGİL, Meral KOZAN, Orhan TERZİOĞLU, Mert ÖZBAKKALOĞLU, Filiz ÖZERKAN, Abdi SAĞCAN | 30–35 |
| Congenital long QT syndrome in relation to a case report | Hüsniye YÜKSEL, Nuran YAZICIOĞLU, Cengiz ÇELİKER, Cengizhan TÜRKOĞLU, Murat BAŞKURT | 49–53 |